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Abstract  
 
Few suitable instruments exist for use with people, especially children, with both 
epilepsy and learning disabilities. One such measure is the Epilepsy and Learning 
Disabilities Quality of Life scale (ELDQOL), which has recently undergone revision 
following feedback from relevant users. This paper reports on the final psychometric 
testing phase of ELDQOL. ELDQOL consists of 70 items covering seizure severity, 
seizure-related injuries, AED side-effects, behaviour, mood, physical, cognitive and 
social functioning, parental concern, communication, overall QOL and overall health.  
Revalidation involved a qualitative phase to ascertain users’ opinions on the wording, 
coverage and layout of the questionnaire; and a quantitative phase to examine internal 
consistency and test-retest reliability, and validity. The final version of ELDQOL has 
very good evidence of reliability and validity, making it a promising instrument for 
assessing QOL in children/young adults with epilepsy and learning disability.   
Word Count: 138
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Introduction 
 
There is general agreement within the health outcomes field of the importance of 
assessing therapeutic outcomes including quality of life (QOL).
1
 Medical interventions
 
may be beneficial to patients on impairment or disability measures,
 
but without equally 
refined QOL measurements a clear and comprehensive
 
evaluation of their efficacy is 
not possible.
2,3
  The assessment of QOL in adults with epilepsy is now widespread with 
the existence of a number of psychometrically sound measures.
4
  However, reviews of 
outcome measures have shown that few suitable instruments currently exist for use 
with people who have both epilepsy and learning disabilities.
1,5
 
 
One recently developed measure, the Epilepsy Outcome Scale (EOS),
6
 was developed 
to be completed by carers of people with epilepsy and learning disabilities (LD), but  
while valid and reliable, it is intended for adults rather than children with these 
conditions.  A recent review of QOL measures for use specifically with children and 
adolescents with epilepsy
1 
identified five epilepsy-specific instruments, of which three 
were considered potentially suitable for children who had LD: the Health-related 
Quality of Life in Children with Epilepsy measure;
 7
 the Impact of Childhood 
Neurological Disability Scale (ICND);
 8
 and the Epilepsy and Learning Disabilities 
Quality of Life scale (ELDQOL).
9-12
 
 
The Health-related Quality of Life in Children with Epilepsy measure was not 
purposely developed for those with both epilepsy and LD.  However, it does 
incorporate a self-report (completed by the child) as well as a proxy-report which can 
be completed by parents alongside or instead of the child report, and seems to be 
reasonably valid and reliable.
1
  The ICND assesses the impact of epilepsy and 
concomitant behavioural, cognitive, and physical/neurological disability in children. It 
has good reliability and is reported to be satisfactory in terms of validity.
1
 
 
ELDQOL is specifically aimed at informal/formal carers of children with both severe 
epilepsy and LD.  Initial evidence of its psychometric properties was reported by the 
scale’s developers13, and subsequently ELDQOL was reviewed by Espie et al5 who also 
reported evidence of internal and test-retest reliability, and some evidence of 
sensitivity.  ELDQOL has been used in two studies, results of which have been 
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reported.
11,14
  
 
However, as a result of feedback from clinicians involved, it was decided to undertake 
revision and revalidation of ELDQOL. This paper reports on the psychometric testing 
of the final, revised version of ELDQOL.  A detailed report of the earlier stages in its 
development is available from one of the authors (AJ).  A summary of its history will be 
provided here.  
 
Initial development of ELDQOL 
 
Potential items for inclusion in the pilot structured measure were selected based on 
in-depth interviews with parents of children with severe epilepsy.  The measure was 
then piloted to assess its psychometric properties (content and construct validity, 
internal consistency and test-retest reliability) and acceptability to parents.  Parents of 
50 patients across 5 UK paediatric neurology out-patient departments were recruited to 
the pilot study. 
 
The pilot version of ELDQOL consisted of 66 items across 6 domains: seizure severity, 
seizure-related injuries, AED side-effects, behaviour, mood and overall QOL.  It was 
found to be satisfactory in terms of content and construct validity and internal 
consistency, and showed high test-retest reliability. Furthermore, parents commented 
that the measure was comprehensive, relevant and easy to complete. The pilot version 
of ELDQOL was subsequently used in a clinical trial of Lamictal
11
 which provided 
evidence of its responsiveness.  However, a number of criticisms were made about the 
measure by clinicians involved in the trials, particularly in terms of the clarity of 
meaning of several items and of the appropriateness or sensitivity of response sets. 
 
Consequently, a revalidation study was undertaken to pre-test (using cognitive 
interviews
15
), revise and then reassess the psychometric properties of ELDQOL.  The 
purpose of this paper is to describe this final phase in the development of the measure 
and report its psychometric properties. 
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Methods 
 
Qualitative phase 
 
Qualitative (cognitive) interviews were undertaken with 16 parents and 17 health and 
other professionals in order to ascertain their opinions on the wording, coverage and 
layout of the questionnaire. 
 
The parent participant group comprised 5 couples (the young person’s mother and 
father) and 6 mothers. The 11 children of these parents were 8 boys and 3 girls, age 
range 18 months to 21 years.  Two young people attended residential school, 7 attended 
special schools or day centres, and one a mainstream school.  The parents were 
identified by a consultant or senior nurse at 2 specialist hospitals in the north of 
England.  They were selected because of their child’s condition and because they were 
judged to be interested in all aspects of their care.  
 
The professional participant group consisted of 10 consultant paediatric neurologists or 
neurologists with a special interest in epilepsy and learning disabilities, one associated 
health services researcher, two paediatric epilepsy nurse specialists, two nurses 
specialising in epilepsy and learning disabilities, two teachers/play leaders, and one 
psychologist. 
 
All participants were sent a copy of the existing ELDQOL questionnaire and asked to 
complete it immediately prior to the in-depth interview.  Interviews were tape recorded 
and lasted approximately one hour.  They involved scrutiny of each question in turn, 
where participants’ views were sought on interpretation, coverage, content, wording 
and scale construction.  The tapes were transcribed for analysis. 
 
Psychometric phase 
 
Following revision based on the findings of the cognitive interviews, the final version 
of ELDQOL was administered in a postal survey to 47 parents/guardians and 21 formal 
carers of children with epilepsy and learning disabilities.  The parents were identified 
by consultant paediatric neurologists and epilepsy specialist nurses at 4 UK hospitals, 
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who explained the study and asked whether they would be willing to complete the 
questionnaire.  Those who agreed were sent a study information sheet together with a 
copy of the questionnaire and a consent form and asked to return both when they had 
been completed.  For the purposes of evaluating test-retest reliability, parents were sent 
a second questionnaire approximately 2 weeks after completing the first.  Formal carers 
were identified through a national long-stay residential/assessment centre. 
 
The mean age of children recruited to the study was 11.5 years (SD 4.6, range 2 – 191); 
58% were male and 42% female. Of the parent respondents, 39 were mothers, 3 were 
fathers, and 2 were other relatives; 3 of the questionnaires were jointly completed by 
both parents.  
 
The final version consisted of 70 items covering seizure severity, seizure-related 
injuries, AED side-effects, behaviour, mood, physical functioning, cognitive 
functioning, social functioning, parental concern, communication, overall QOL and 
overall health.  The items covering behaviour, seizure severity, mood and side-effects 
domains are summed to create 4 subscales containing 9, 14, 16 and 19 items 
respectively.  On each subscale, a higher score indicates poorer functioning. The 
remaining domains consist of single or several non-summed items.  Subscales from two 
other outcome measures [the Aberrant Behavior Checklist (ABC)
16 
and the Child 
Health Questionnaire (CHQ)]
17
 were also administered for the purposes of evaluating 
the construct validity of ELDQOL. 
 
In order to evaluate validity, t-tests and correlations were used to examine the 
relationship between ELDQOL sub-scales and:  
 
* the Irritability and Hyperactivity subscales of the ABC; 
 
* the Impact on Parental Time, Emotional Impact on Parent, and Family 
Activities sub-scales of the CHQ; 
 
* 4 global items (overall health, overall QOL, perceived severity of condition and 
                                                          
1
 Age was not recorded for 13 children. 
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disability level). 
 
Severity of disability was assessed using a 4-item scale developed by a consultant 
paediatric neurologist (RA) with a specialist interest in epilepsy and learning disability.  
It covers mobility, feeding, dressing and speech, each item having 5 response options 
ranging from the worst to the best possible level of functioning. 
 
It was predicted a priori that there would be: 
 
* a significant relationship between the ABC Irritability and Hyperactivity scales 
and scores on each ELDQOL subscale; 
 
* a significant relationship between the 3 CHQ scales and scores on each 
ELDQOL subscale; 
 
* a significant relationship between overall health and scores on each ELDQOL 
subscale; 
 
* A significant relationship between overall QOL and scores on the Side-Effects, 
Seizure Severity, and Mood subscales 
 
* A significant relationship between perceived severity of condition and each 
subscale 
 
* A significant relationship between disability level and Seizure Severity. 
 
Internal consistency of the 4 sub-scales was assessed using Cronbach’s alpha 
coefficients and item-total correlations.  Test-retest reliability was assessed using 
intraclass correlation coefficients.  Floor and ceiling effects for each subscale were 
examined. 
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Results 
 
Qualitative phase 
 
Views of parents 
 
Six issues were identified through the cognitive interviews with parents: validity of 
domains, multiple seizure types, wording, ease of completion, response categories and 
identifying change. It was clear that the questionnaire resonated with parents’ 
experiences and concerns, the questions being described as ‘very good’ and ‘geared to 
parents’ for example.   However, it did not, in its existing form, take into account that 
some children have no mobility or verbal skills.  Some commented on the lack of 
lifestyle questions to capture social activities and interests. In terms of multiple seizure 
types, some parents found it difficult to identify which seizure type they should refer to 
in answering the questions.  There was a consensus that use of the word ‘seizure’ was 
preferable to ‘attack’.   The ‘layman’s language’ was appreciated because it was easy to 
understand, and the length of the questionnaire was viewed as good, ‘quick to do’ and 
‘easily to fill in’.  Instructions were described as ‘clear’, ‘logical’ and ‘concise’.  
Overall, parents felt that they had sufficient choice in response categories, and being 
asked to concentrate on the past 4 weeks seemed acceptable. 
 
Views of professionals 
 
Interviews with professionals highlighted several broad methodological issues, in 
particular the nature of the proxy respondent, scope and objectives of the questionnaire, 
sensitivity to change, and questionnaire design.  Participants felt generally that parents 
would be able to answer the majority of the questions and would therefore be 
appropriate proxies. However, there was some reservation regarding the suitability of 
nursing, teaching or respite care staff who may not have known the child for long – ‘it 
would be necessary to know the child inside out’ to be able to complete some of the 
sections of the questionnaire..  In terms of the scope and objectives of the questionnaire, 
its orientation led some to query what was being sought and by whom it would be used.  
The addition of socially based QOL questions, a ‘health profile’ and a section covering 
function was suggested. In terms of design, most professionals felt the length of the 
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questionnaire was about right. Some thought the use of the word ‘attack’ was regressive 
in terms of practice and preferred the term ‘seizure’.  
 
Revisions made as a result of the qualitative phase 
 
Taking into account the comments from parents and professionals, a number of 
revisions were made.  In summary:  
 
* the word ‘seizures’ replaced the word ‘attacks’ 
 
* ‘can’t say’ and ‘does not apply’ response options were added  
 
* a question about perceived control was dropped because of ambiguity of 
meaning; and one about perceived severity was added 
 
* an item was added to those about seizure-related injuries 
 
* an item covering ‘usual activities’ (school, playing, socialising) was added to 
the behaviour subscale 
 
* 2 items (‘sociable’ and ‘depressed’) were dropped from the mood subscale and 
replaced by three new ones (‘sad’, ‘withdrawn’, ‘cooperative/helpful’) 
 
*  2 items were dropped from the side effects profile (hair loss, dizziness) and 2 
were added (weight loss, loss of appetite); and a single item, 
‘restlessness/hyperactivity’ was separated into two 
 
* clearer/more detailed instructions were provided (including a statement 
instructing parents/proxies to think about the most severe seizures in the case of 
multiple seizure types, and emphasising that questions relate to the last four 
weeks) 
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Psychometric phase 
 
Reliability 
 
As shown in Table 1, internal consistency of the Behaviour, Seizure Severity, Mood 
and Side-Effects scales was high (0.74 – 0.95). Item-total correlations exceeded the 
desired 0.4 for most items, although in each scale there were some items which did not 
meet this: 3/9 items in the Behaviour Scale (‘problems sleeping‘, ‘being prevented from 
taking part in normal activities‘, and ‘appetite a problem‘); 7/14 items in the Seizure 
Severity scale (‘aware of surroundings after seizure‘, ‘blank out/lose consciousness‘, 
‘fall to the ground‘, ‘soil self‘, ‘injure mouth/cheek /tongue‘, ‘upset by injuries‘, 
‘appear sleepy/subdued‘); 4/16 items in the Mood scale (‘tearful‘, ‘hyperactive‘, 
‘withdrawn‘, ‘cooperative‘); and 3/19 items in the Side-effects scale (‘skin problems‘, 
‘shaky hands‘, ‘weight gain. 
 
The test-retest reliability of each subscale was high (range 0.80 - 0.96, Table 1).  
Floor/ceiling effects were acceptable in the Side Effects scale, low in the Seizure 
Severity scale, and there were none in the Mood or Behaviour scales (Table 1). 
 
Validity 
Table 2 shows that all but one of the 4 ELDQOL subscales (Behaviour) were 
moderately to highly correlated with both the Irritability and Hyperactivity scales of the 
ABC, and that all 4 were moderately to highly correlated with the Emotional Impact 
and Family Activities scales of the CHQ.  Two of the ELDQOL subscales (Seizure 
Severity and Side-effects) correlated moderately with the Impact on Parental Time 
scale of the CHQ. 
 
Table 3 shows a significant relationship between mean scores on the Behaviour and 
Mood subscales by overall health.  There was a similar though non-significant trend for 
the Seizure Severity and Side Effects subscales.  
 
As can be seen in Table 4, those with poorer perceived overall QOL tended to have 
higher mean scores on the ELDQOL scales, although these were not statistically 
significant.  
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Mean scores on each of the 4 subscales were significantly worse for parents who felt 
their child’s condition was very severe compared to those who felt it was somewhat or 
moderately severe (Table 5). 
 
The Seizure Severity and Behaviour subscales were significantly correlated with 
severity of disability (Table 6).  No significant correlation was found for the 
Side-Effects and Mood subscales. 
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Discussion 
 
ELDQOL was derived using currently accepted standards for scale development, 
including qualitative and cognitive interview techniques with the target groups. The 
ongoing involvement of parents and professionals in determining the content and 
format of the measure has enhanced its acceptability and ease of completion. The final 
version of ELDQOL has very good evidence of reliability and validity, making it a 
promising proxy instrument for assessing the QOL of children/young adults with 
epilepsy and learning disability.  Although in this validation exercise parents were not 
asked to note length of time taken to complete ELDQOL, this was previously estimated 
as only around 20 minutes
5
, a factor which may further contribute to its acceptability.  
 
In terms of internal consistency, each of the 4 subscales had high Cronbach’s alpha 
values.  For each scale there were some items which did not meet the desired 0.4 level 
for item to total scale correlation.
19
 However, in each case the effect on Cronbach’s 
alpha when these items are removed from the scale is negligible or has no effect and we 
therefore propose to retain these items on the grounds of comprehensiveness/content 
validity. 
 
The test-retest exercise found that each of the 4 subscales achieved ICCs well above the 
required level of 0.70 for group comparisons, and 3 of the 4 performed well enough for 
comparing individuals over time (0.90).
19
  Each scale performed well or perfectly in 
terms of floor/ceiling effects. 
 
We found excellent evidence of construct validity as all but one of the 4 ELDQOL 
subscales (Behaviour) were moderately to highly correlated with both the Irritability 
and Hyperactivity scales of the ABC, and all were moderately to highly correlated with 
the Emotional Impact and Family Activities scales of the CHQ.   Poorer perceived 
health was significantly related to poorer mean scores on two of the ELDQOL 
subscales, and a similar trend was seen for the remaining two, providing further 
evidence of construct validity.  Greater perceived severity of the condition was 
significantly related to higher scores on each subscale, and  disability level was 
significantly correlated with scores on the Seizure Severity and Behaviour scales. 
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Although the sample size was relatively small we would suggest that, based on both 
psychometric analysis and feedback from parents, ELDQOL will be a valuable 
contribution to outcomes measurement in childhood epilepsy and learning disability, 
particularly in the context of treatment trials, but also, with the addition of new items to 
address parent and professional concerns over coverage and content validity, in a wider 
research context.  Further studies are needed to assess its responsiveness to change. 
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Table 1 Reliability and floor/ceiling effects of the 4 ELDQOL subscales 
 
 
 
ELDQOL 
Subscale 
 
Cronbach’s 
alpha 
 
Item-total 
correlations 
 
Intraclass 
correlation 
(test-retest) 
 
Floor / 
ceiling 
effects (%) 
 
Behaviour 
 
0.79 
 
.24 - .70 
 
0.80 
 
0 / 0 
 
Seizure 
Severity 
 
0.74 
 
.19 - .54 
 
0.96 
 
2 / 0 
 
Mood 
 
0.86 
 
.21 - .78 
 
0.91 
 
0 / 0 
 
Side-effects 
 
0.95 
 
.33 - .88 
 
0.92 
 
10 / 0 
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Table 2 Validity: correlation between the 4 ELDQOL sub-scales and ABC 
and GHQ sub-scales
1 
 
 
ELDQOL 
subscale: 
 
ABC subscales 
 
 
CHQ subscales 
 Irritability Hyperactivity Impact on 
Parental 
Time 
Emotional 
Impact on 
Parent 
Family 
Activities 
 
Behaviour 
 
r=0.008 
p=0.95 
 
r=0.13 
p=0.32 
 
r=0.25 
p=0.1 
 
r=-0.42 
p<0.01 
 
r=-0.31 
p<0.05 
 
Seizure 
Severity 
 
r=0.29 
p<0.05 
 
r=0.38 
p<0.01 
 
r=-0.33 
p<0.05 
 
r=-0.47 
p<0.01 
 
r=-0.48 
p<0.01 
 
Mood 
 
r=0.74 
p<0.001 
 
r=0.56 
p<0.001 
 
r=-0.28 
p=0.06 
 
r=-0.48 
p<0.01 
 
r=-0.63 
p<0.001 
 
Side-effects 
 
r=0.38 
p<0.02 
 
r=0.39 
p=0.01 
 
r=-0.43 
p<0.01 
 
r=-0.54 
p<0.001 
 
r=-0.47 
p<0.01 
 
1
 Pearson’s correlation coefficient 
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Table 3 Validity: mean scores of the 4 ELDQOL subscales by overall health 
 
  
Overall health: 
  
  
Very 
good/good 
 
Fair/poor/v 
poor 
 
t test 
 
p value 
 
Seizure severity 
 
26 
 
31 
 
-1.8 
 
0.08 
 
Side-effects 
Profile 
 
30  
 
37 
 
 -1.9 
 
0.06 
 
Behaviour Scale 
 
17 
 
21 
 
-3.6 
 
0.001 
 
Mood 
 
 
32 
 
35 
 
-2.1 
 
0.038 
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Table 4 Validity: mean scores of the 4 ELDQOL subscales by overall QOL 
 
  
Overall QOL: 
  
  
Very 
god/good 
 
Fair/poor/v 
poor 
 
t test 
 
P value 
 
Seizure severity 
 
29 
 
30 
 
-0.2 
 
0.81 
 
Side-effects 
Profile 
 
30 
 
36 
 
-1.4 
 
0.16 
 
Behaviour Scale 
 
17 
 
19 
 
-1.8 
 
0.078 
 
Mood 
 
32 
 
35 
 
-1.8 
 
0.071 
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Table 5 Validity: mean scores of the 4 ELDQOL subscales by perceived 
severity of condition 
 
  
How severe: 
  
  
Very 
 
Somewhat/moderate/ 
Mild 
 
t test 
 
p value 
 
Seizure severity 
 
35 
 
24 
 
4.3 
 
<.001 
 
Side-effects 
Profile 
 
43 
 
32 
 
2.9 
 
<0.01 
 
Behaviour Scale 
 
21 
 
17 
 
3.1 
 
<.01 
 
Mood 
 
37 
 
31 
 
2.4 
 
<.03 
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Table 6 Validity: correlation between ELDQOL subscales and disability 
level 
 
 
 
Scale 
 
Pearson’s r 
 
p value 
 
Seizure severity 
 
-0.43 
 
.001 
 
Side Effects Profile 
 
0.02 
 
.93 
 
Behaviour scale 
 
0.44 
 
.000 
 
Mood 
 
-0.1 
 
.41 
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